104 related articles for article (PubMed ID: 1802984)
1. Boundary and airlock design issues in aseptic facilities.
Lorenz MR; Robinson JE
J Parenter Sci Technol; 1991; 45(6):279-85. PubMed ID: 1802984
[TBL] [Abstract][Full Text] [Related]
2. Panel discussion: Environmental sampling in an aseptic environment. III. Cross contamination control.
Elias WF
Bull Parenter Drug Assoc; 1974; 28(6):263-9. PubMed ID: 4455322
[No Abstract] [Full Text] [Related]
3. Design control and validation of a facility for sterile clinical trial preparations.
Staines L
J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
[No Abstract] [Full Text] [Related]
4. The influence of clean room design on product contamination.
Whyte W
J Parenter Sci Technol; 1984; 38(3):103-8. PubMed ID: 6747777
[No Abstract] [Full Text] [Related]
5. Proposal for a new categorization of aseptic processing facilities based on risk assessment scores.
Katayama H; Toda A; Tokunaga Y; Katoh S
PDA J Pharm Sci Technol; 2008; 62(4):235-43. PubMed ID: 19174952
[TBL] [Abstract][Full Text] [Related]
6. Control aspects of aseptically produced products.
Avallone HL
J Parenter Sci Technol; 1985; 39(2):75-9. PubMed ID: 3989616
[No Abstract] [Full Text] [Related]
7. Aseptic processing contamination case studies and the pharmaceutical quality system.
Friedman RL
PDA J Pharm Sci Technol; 2005; 59(2):118-26. PubMed ID: 15971544
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing.
Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL
PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281
[TBL] [Abstract][Full Text] [Related]
9. FDA's aseptic processing: proposed regulation.
Barr DB
J Parenter Sci Technol; 1993; 47(2):57-9. PubMed ID: 8515345
[No Abstract] [Full Text] [Related]
10. Control of the aseptic processing environment.
Frieben WR
Am J Hosp Pharm; 1983 Nov; 40(11):1928-35. PubMed ID: 6650522
[TBL] [Abstract][Full Text] [Related]
11. Panel discussion: environmental sampling in an aseptic environment. I. Microbiological environmental monitoring.
Raiman HL
Bull Parenter Drug Assoc; 1974; 28(6):253-60. PubMed ID: 4616742
[No Abstract] [Full Text] [Related]
12. Evaluating aseptic technique of pharmacy personnel.
Brier KL
Am J Hosp Pharm; 1983 Mar; 40(3):400-3. PubMed ID: 6342376
[TBL] [Abstract][Full Text] [Related]
13. Validation of environmental monitoring methods and levels.
Noble NH
J Parenter Sci Technol; 1993; 47(1):26-8. PubMed ID: 8445496
[TBL] [Abstract][Full Text] [Related]
14. Microbiological validation of a new manufacturing complex for an injectable biological product.
Carroll MC; Van Pala M; Vollherbst L
J Parenter Sci Technol; 1992; 46(4):107-10. PubMed ID: 1453278
[TBL] [Abstract][Full Text] [Related]
15. Development of a non-viable particulate monitoring system for drugs manufactured in an aseptic environment.
Morgan N
J Parenter Sci Technol; 1991; 45(6):260-5. PubMed ID: 1802980
[TBL] [Abstract][Full Text] [Related]
16. [Microbiological in-process control in drug manufacture].
Seyfarth VH
Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162
[TBL] [Abstract][Full Text] [Related]
17. Aseptic methods for removing fluids from small-volume parenterals.
Nagata RE; Mock ED; Reynolds G; Moriyama W; Schalker WL
Hosp Pharm; 1977 Mar; 12(3):118-9, 122-6. PubMed ID: 10235811
[No Abstract] [Full Text] [Related]
18. Current practices in the validation of aseptic processing--1992.
Agalloco J; Akers J
J Parenter Sci Technol; 1993; 47 Suppl 1():S1-21. PubMed ID: 8515352
[No Abstract] [Full Text] [Related]
19. In line validation of sanitizing agents in aseptic processing areas.
Chesky SR
J Parenter Sci Technol; 1986; 40(4):169-74. PubMed ID: 3095529
[No Abstract] [Full Text] [Related]
20. Risk management, cGMP, and the evolution of aseptic processing technology.
Agalloco J; Akers J; Baseman H; Boeh R; Madsen R; Ostrove S; Pavell A
PDA J Pharm Sci Technol; 2009; 63(1):8-10. PubMed ID: 19455938
[No Abstract] [Full Text] [Related]
[Next] [New Search]
